Engineered Microorganisms for Syngas Conversion to 1,3-Butanediol
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current organisms capable of utilizing syngas for chemical production are poorly characterized, intolerant to high concentrations of products like butanol, produce multiple unwanted products, and lack genetic tools for improvement, limiting the commercialization of 1,3-butanediol production.
Innovation Solution
Development of non-naturally occurring microbial organisms with engineered pathways that include specific enzymes to efficiently convert carbohydrates, methanol, and syngas into 1,3-butanediol, utilizing the Wood-Ljungdahl pathway and MtaABC-type methyltransferase system to optimize production.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If known organisms (Clostridium spp.) are used for syngas utilization, then syngas conversion capability is achieved, but product tolerance is poor and commercialization is limited
Solution Approach 1:
The patent uses a heterologous expression system where the target pathway enzymes are expressed in a robust host organism (E. coli or C. glutamicum) rather than attempting to improve the native syngas-utilizing organisms. This approach treats the expression system as a disposable platform that can be rapidly engineered and optimized without being constrained by the physiological limitations of the original syngas-utilizing Clostridium species.
Solution Approach 2:
The patent fundamentally changes the host organism parameters from native syngas-utilizing Clostridium species to model organisms with well-established genetic tools (E. coli, C. glutamicum). This parameter change enables better product tolerance, higher productivity, and easier genetic manipulation while maintaining syngas conversion capability through heterologous expression of the required pathway enzymes.
2Productivity
If Clostridium organisms are used for 1,3-BDO production, then syngas utilization is achieved, but product selectivity is poor due to multiple product formation
Solution Approach 1:
The patent extracts only the essential syngas utilization capability (acetyl-CoA synthase/CO dehydrogenase complex) from Clostridium organisms and transfers it to host organisms that naturally produce fewer byproducts. This extraction approach separates the syngas conversion function from the problematic multiple product formation, allowing selective production of 1,3-BDO.
Solution Approach 2:
The patent uses universal host organisms (E. coli, C. glutamicum) that can perform multiple functions: they can utilize syngas through heterologous expression of acetyl-CoA synthase, produce 1,3-BDO through the engineered pathway, and maintain robust growth characteristics. This multi-functionality in a single host system resolves the selectivity issue by consolidating all desired functions in an organism optimized for high-yield single product formation.
3Adaptability or versatility
If Clostridium organisms are used for syngas conversion, then natural syngas utilization capability is achieved, but genetic manipulation is difficult
Solution Approach 1:
The patent introduces an intermediary system - heterologous expression of the acetyl-CoA synthase/CO dehydrogenase complex from Clostridium in model organisms. This intermediary approach allows the benefits of Clostridium's natural syngas utilization to be harnessed while avoiding its genetic manipulation limitations, as the host organisms have well-developed genetic tools for precise yield optimization.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The engineered organisms achieve high yields of 1,3-butanediol from diverse carbon sources, including syngas and methanol, with improved tolerance and selectivity, reducing production costs and environmental impact.
Implementation Method 1
utilizing the Wood-Ljungdahl pathway and MtaABC-type methyltransferase system to optimize production
Implementation Method 2
MtaABC-type methyltransferase system
Data Source
AI summary
A non-naturally occurring microbial organism having a 1,3-butanediol (1,3-BDO) pathway includes at least one exogenous nucleic acid encoding a 1,3-BDO pathway enzyme or protein expressed in a sufficient amount to produce 1,3-BDO. A method for producing 1,3-BDO that includes culturing the this non-naturally occurring microbial organism under conditions and for a sufficient period of time to produce 1,3-BDO.